Top
The program aims at
- Developing clinically-relevant, patient-derived, phenotypically responsive, adult stem cell based predictive platforms to test therapeutic vulnerabilities of molecules trans-differentiating adult stem cells to neurons
- Developing novel natural product-inspired functional, druggable molecular entities with neurogenesis and neuroprotective properties for treating neurological disorders
- Integrating highly unique chemical toolbox with proprietary stem cell based predictive screening platform(s) to discover novel small molecules, functioning as neuro-genesis and neuro-protective agents to treat Alzheimer’s, Parkinson’s and ALS
- To explore PINK and Parkin as targets in Neurodegeneration
The program aims at
- Developing novel mesenchymal stem cell based formulae as bio candidates regenerating muscles
- Developing new methodologies for large scale production of clinical grade progenitor cells retaining characteristics
- To develop methods to biobank patient sourced primary cells in creating gene signatures
No Comments
Sorry, the comment form is closed at this time.